NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions?

CompletedPhase 4

Sponsor: Aarhus University Hospital Skejby

Conditions: Coronary Artery Disease

Interventions: Percutaneous coronary intervention

Countries: Denmark

How to use drug eluting stents (DES) in bifurcation lesions. A strategy of routine stenting of both main vessel and side branch versus a strategy of routine main vessel stenting and optional treatment of side branch. A randomized Nordic multicenter study including 400 patients with angina pectoris with clinical angiographic follow-up.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Stable or unstable AP.
* Bifurcation lesion of "LAD/diagonal", "Cx/obtuse marginal", "RCA-PDA/posterolateral branch or LM/Cx/LAD in a right dominant system.
* Diameter of main vessel by visual estimate \> 2.5 mm.
* Diameter of side branch by visual estimate \> 2.0 mm.
* Signed informed consent.

Exclusion Criteria:

* ST-elevation AMI within 24 hours.
* Expected survival \< 1 year.
* S-creatinine \> 200 Umol/l.
* Allergy to Aspirin, Clopidogrel or Ticlopidine.
* Allergy to sirolimus/paclitaxel.
* Left main bifurcation in a non-right dominant system.

Locations (1)

Aarhus, Denmark